DNA encoded libraries are becoming increasingly popular due to their access to the largest chemical space available in the market. This has been driven by several technological advancements and the growing demand for effective techniques for screening of potential drug targets. Companies such as Insitro, Google Research, and Relay Therapeutics have been leveraging artificial intelligence and machine learning to integrate DNA encoded libraries into their drug discovery platforms. Currently, there are around 50 companies offering DNA encoded libraries and affiliated services for drug discovery across different regions of the world. These companies are offering DNA encoded libraries for a myriad of drug discovery services, with the majority providing different types of library screening services.
